CGRP Monoclonal Antibodies and Fracture Risk at One Year in Veterans with Migraine

Aimovig (erenumab-aooe) - Amgen

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

Ney, J.P.1; Laffargue, E.2; Grinberg, A.S.3; Skanderson, M.4; Rogers, D.5; Laferriere, C.6; Sico, J.J.7

Jun 11, 2026